Drug Approval | October 16, 2024
Enhertu approved in China as first HER2-directed therapy for patients with HER2-mutant metastatic NSCLC
Enhertu demonstrated clinically meaningful efficacy in previously treated patients
Enhertu demonstrated clinically meaningful efficacy in previously treated patients
The partnership marks a pivotal step towards developing new therapies for combating Sickle Cell Disease
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
To set a new standard in oncology, offering highly targeted radiation therapy that improves treatment precision, and accelerates recovery for cancer patients
WCK 6777 is the only once-a-day drug in global antibiotic pipeline designed for outpatient parenteral antimicrobial therapy
The acquisition will strengthen the overall company’s position as leading global CRO services partner
Poor oral health (periodontal disease) impacts nearly 51% of Indians
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
This office will be the central hub for all operations related to companies ethical pharmaceutical business
Subscribe To Our Newsletter & Stay Updated
